Clinical trial
Transrectal Tumour Oxygen - US Army
NCT00160979 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00160979 |
|---|---|
| Title | Transrectal Tumour Oxygen - US Army |
| Official title | A Study of Transrectal Tumour Oxygen Measurements in Patients With Clinically Localized Prostate Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | U.S. Army Medical Research and Development Command U.S. Fed Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Procedure |
| Interventions | Pre-treatment tumour oxygen measurements |
| Enrollment | 195 |
| Start date | Jan 1, 2001 |
| Primary completion | Feb 1, 2023 |
| Completion | Feb 1, 2023 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 27, 2024 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: